Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: A randomized, double-blind, placebo-controlled trial

Clinical Nutrition

Volumn 29, Issue 3, 2010, Pages 312-316

  Hojsak, Iva ^a   Snovak, Natalija ^b   Abdović, Slaven ^a   Szajewska, Hania ^c   Mišak, Zrinjka ^a   Kolaček, Sanja ^a  

^a Croatia   (Croatia)

^b Dr Ivo Pedi i General Hospital   (Croatia)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Children; Day care center; Infection; LGG; Prevention; Probiotics

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ARTICLE; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; COLONY FORMING UNIT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAY CARE; DIARRHEA; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL INFECTION; HUMAN; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS RHAMNOSUS GG; MAJOR CLINICAL STUDY; MALE; MILK; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; RISK REDUCTION; VOMITING; AGING; DAIRY PRODUCT; FOOD CONTROL; GASTROENTERITIS; INFANT; INFECTION CONTROL; MICROBIOLOGY; PROCEDURES; RESPIRATORY TRACT INFECTIONS; SEXUAL DEVELOPMENT; STATISTICS; TIME;

AGING; CHILD; CHILD DAY CARE CENTERS; CULTURED MILK PRODUCTS; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; FOOD MICROBIOLOGY; GASTROENTERITIS; HUMANS; INFANT; INFECTION CONTROL; LACTOBACILLUS RHAMNOSUS; MALE; PROBIOTICS; RESPIRATORY TRACT INFECTIONS; SEX CHARACTERISTICS; STATISTICS AS TOPIC; TIME FACTORS; VOMITING;

EID: 77953546160     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2009.09.008     Document Type: Article

References (19)

1. Lu N., Samuels M.E., Shi L., Baker S.L., Glover S.H., Sanders J.M. Child day care risks of common infectious diseases revisited. Child Care Health Dev 2004, 30:361-368.
2. Landis S.E., Chang A. Child care options for ill children. Pediatrics 1991, 88:705-718.
3. Carpenter E.S. Children's health care and the changing role of women. Med Care 1980, 18:1208-1218.
4. Oberhelman R.A., Gilman R.H., Sheen P., Taylor D.N., Black R.E., Cabrera L., et al. A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr 1999, 134:15-20.
5. de Vrese M., Winkler P., Rautenberg P., Harder T., Noah C., Laue C., et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin Nutr 2005, 24:481-491.
6. Kukkonen K., Savilahti E., Haahtela T., Juntunen-Backman K., Korpela R., Poussa T., et al. Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics 2008, 122:8-12.
7. Weizman Z., Asli G., Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 2005, 115:5-9.
8. Hatakka K., Savilahti E., Ponka A., Meurman J.H., Poussa T., Näse L., et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 2001, 322:1327-1331.
9. Thibault H., Aubert-Jacquin C., Goulet O. Effects of long-term consumption of a fermented infant formula (with Bifidobacterium breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants. J Pediatr Gastroenterol Nutr 2004, 39:147-152.
10. Saavedra J.M. Use of probiotics in pediatrics: rationale, mechanisms of action, and practical aspects. Nutr Clin Pract 2007, 22:351-365.
11. Isolauri E., Sutas Y., Kankaanpaa P., Arvilommi H., Salminen S. Probiotics: effects on immunity. Am J Clin Nutr 2001, 73:444S-450S.
12. Chiang B.L., Sheih Y.H., Wang L.H., Liao C.K., Gill H.S. Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses. Eur J Clin Nutr 2000, 54:849-855.
13. Rinne M., Kalliomaki M., Arvilommi H., Salminen S., Isolauri E. Effect of probiotics and breastfeeding on the Bifidobacterium and Lactobacillus/enterococcus microbiota and humoral immune responses. J Pediatr 2005, 147:186-191.
14. Viljanen M., Kuitunen M., Haahtela T., Juntunen-Backman K., Korpela R., Savilahti E. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr Allergy Immunol 2005, 16:65-71.
15. Isolauri E., Joensuu J., Suomalainen H., Luomala M., Vesikari T. Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 1995, 13(3):310-312.
16. Isolauri E., Arvola T., Sutas Y., Moilanen E., Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000, 30:1604-1610.
17. Pessi T., Sutas Y., Hurme M., Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 2000, 30:1804-1808.
18. Majamaa H., Isolauri E., Saxelin M., Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995, 20:333-338.
19. Moher D., Schulz K.F., Altman D.G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001, 357:1191-1194.